Press "Enter" to skip to content

Demand for vancomycin to scale new heights at a CAGR of 5.8% as market players focus on innovations: Fact.MR Research

© Brett Jordan

As per industry analysis on vancomycin by Fact.MR, a market research and competitive intelligence provider, the global market is predicted to expand at a CAGR of 5.8% over the forecast period and reach US$ 465.1 Mn by 2027.

The human body is home to a wide range of microorganisms. Staphylococcus aureus, a gram-positive bacterium that is most typically found on the human skin and nasal passages, is one of them. The market for vancomycin is developing due to increasing prevalence of this infection. Increasing government and non-government awareness campaigns are also expected to contribute to market growth. 

The global vancomycin market is being driven by increased incidence of diseases caused by vancomycin-resistant Staphylococcus aureus (VRSA), and poor sanitation, which, in turn, increases the risk of hospital-acquired infections.

VRSA infections can be treated with a range of commercially available drugs, but maintaining basic sanitary conditions, including wound care, hand washing before and after direct contact with patients, and the use of disposable gloves, is the most effective strategy for preventing the spread of VRSA.

Vancomycin is used as a first-line and second-line treatment, depending on the diseases for which it is prescribed. The global market for vancomycin is predicted to rise over the next years owing to increasing demand for antibiotics. The market is reliant on the number of processed prescriptions for cases, which is increasing at an unprecedented rate.

Request a sample to get extensive insights into the Vancomycin Demand at 

Key Takeaways from Market Study

  • Global vancomycin market to reach US$ 465.1 valuation Mn by 2027.
  • Market in Germany projected to rise at a CAGR of 4% over the forecast period.
  • Market in Canada to record 4.6% CAGR over the forecast period of 2021-2027.
  • China vancomycin market forecast to reach size of US$ 102.3 Mn by 2027.

Healthcare beneficiaries play a key part in the movement, influencing corporations to develop pharmaceuticals for comprehensive treatment. Rising initiatives by government organizations for the development of novel drugs and treatments are supporting vancomycin market growth,” says a Fact.MR analyst

Winning Strategy

To increase their market position across geographies, vancomycin suppliers are investing in the research and development of new medicines. Key players are also working hard to secure regulatory approvals for their products.

For instance,

  • In 2019, Rutgers University researchers identified two genes that make illnesses such as VRSA resistant to therapy.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Daptomycin Sales Report

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global vancomycin market, presenting historical demand data (2017-2020) and forecast statistics for the period of 2021-2027.

The study divulges essential insights on the market on the basis of type (daptomycin, linezolid, quinupristin, ampicillin, chloramphenicol, and others) and application (sepsis, lung infection, skin soft tissue infection, colitis & intestinal inflammation, and other infections), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).

Key Segments Covered in Vancomycin Industry Research

  • Vancomycin Market by Type :
    • Daptomycin
    • Linezolid
    • Quinupristin
    • Ampicillin
    • Chloramphenicol
    • Others
  • Vancomycin Market by Application :
    • Sepsis
    • Lung Infection
    • Skin Soft Tissue Infection
    • Colitis & Intestinal Inflammation
    • Other Infections
  • Vancomycin Market by Region :
    • North America Vancomycin Market
    • Europe Vancomycin Market
    • Asia Pacific Vancomycin Market
    • Latin America Vancomycin Market
    • MEA Vancomycin Market

Get a glimpse of the in-depth analysis through our Vancomycin Market Sales Report  

Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

To learn more about Linezolid Demand, you can get in touch with our Analyst.

Check out more studies related to Healthcare Industry, conducted by Fact.MR:

Which Key Contributors are Driving Coronary Stents Market Growth? – Coronary stenting is recommended for patients who have a blocked coronary artery. For individuals with acute coronary artery blockages, angioplasty is the first line of treatment.

What are the Reasons for the Rapid Growth of the Spectrometry Market? – Spectrometry techniques make use of cutting-edge technology. The innovation in handheld and portable instruments necessary for spectrometry processes is driving the worldwide spectrometry market.

What Impact Does High Prevalence of Chronic Diseases Have on This Market?- Increasing demand for rapid diagnosis and rising prevalence of chronic diseases will majorly favor demand for point of care testing solutions such as dipstick POC, lateral flow assay-based POC tests, microfluidic point-of-care testing, etc.

What Will Majorly Influence Bipolar Disorder Therapeutics Market Size through 2026? – Demand for ADHD therapeutics, autism therapeutics, and seasonal affective disorder therapeutics is also expected to rise throughout the forecast period.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Sponsored by Fact.MR